Skip to main content

Animations

MJFF Publications

1831 - 1840 of 8785 Results
Title
Year
  • Year
  • 2011
  • 2017
  • 2010
  • 2018
  • 2017
  • 2023
  • 2025
  • 2023
  • 2023
  • 2025
  • Summary Details
    OPEN
    Title: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70175-2
    Citation Count: 325
  • Summary Details
    OPEN
    Title: Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20170803
    Citation Count: 164
  • Summary Details
    OPEN
    Title: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevin
    Journal Name: NeuroReport
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3b
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand
    Journal Name: Cell Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cmet.2017.12.008
    Citation Count: 534
  • Summary Details
    OPEN
    Title: Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000004609
    Citation Count: 145
  • Summary Details
    OPEN
    Title: Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1007/s11481-023-10094-7
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Sex differences in the diagnosis latency of Parkinson's disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107344
    Citation Count: 0
  • Summary Details
    OPEN
    Title: G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom13030473
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Valbenazine as treatment for Huntington's disease chorea
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Longitudinal assessment of the association between pesticide exposure and lifestyle with Parkinson’s disease motor severity
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01010-2
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.